Designed to Disappear: A Different Kind of Power in Medicine

An experimental battery that breaks down after use invites a bigger question: how could designing technology’s departure improve the care it delivers?

For a patient, the value of a medical device lies in what it makes possible: an answer, a treatment, a better understanding of what is happening inside their body. The machinery behind that benefit should demand as little of them as possible.

That ambition creates a difficult engineering challenge. A device small enough to swallow may still need electricity to sense, communicate or deliver treatment. Its power source must perform in a demanding environment. And once its work is finished, everything that entered the body has to go somewhere.

A research team led by Mehmet Girayhan Say and Giovanni Traverso has developed a battery with that ending built into its design.

Described in Nature Chemical Engineering on September 21, the bioresorbable battery powered ingestible electronic devices in studies involving pigs. Its materials are designed to break down after use—a promising step toward medical electronics whose useful life can be matched more closely to the task they perform.

The discovery sits where Life Sciences and Industrial Sciences meet. Understanding the body’s needs and responses informs what the device must do; advances in materials and engineering determine how it can do that work, and what happens afterward.

The team’s battery combines magnesium and molybdenum trioxide electrodes with a gel electrolyte. These components enable it to generate electricity while allowing the power source to degrade over time. Researchers demonstrated its operation in two applications: wireless tracking of an ingestible capsule and electrical stimulation within the stomach.

For Say, the study’s lead author and a former MIT postdoctoral researcher, demonstrating useful function was central to the achievement.

“It can actually power clinically relevant functions inside the gastrointestinal tract and then simply dissolve,” he told MIT News.

That sentence captures the balance at the heart of the work. A battery that disappears too quickly cannot do its job. One that persists too long undermines the purpose of making it degradable. Performance and disappearance must be engineered together.

Traverso, the study’s senior author, brings both medical and engineering experience to that problem as an MIT professor and a gastroenterologist at Brigham and Women’s Hospital. His group has explored ingestible devices for applications ranging from monitoring the body to delivering therapies. Powering those systems introduces its own safety considerations, particularly if a conventional battery’s protective casing fails.

Even the coating becomes consequential. As Traverso explained in reporting by Charles Q. Choi, protecting the battery from stomach fluid long enough to function—while still allowing it to degrade—required careful control. Natural wax helped regulate that process.

Through the lens of Industrial Sciences, this is a challenge of materials, protection and controlled performance. Within Life Sciences, those same design choices become questions about how a device interacts with living tissue and whether it can support better care. Each field gives the other a more demanding definition of success.

For future patients, the potential benefit is technology that can perform a temporary task with fewer lasting demands. Traverso has suggested that a bioresorbable power source could reduce the need to retrieve certain devices designed to remain in the stomach for several days. That possibility remains a research ambition, rather than an established outcome in human care.

The distinction matters. These findings come from preclinical research. Human safety, effectiveness and practical use still need to be established. Nor does a dissolving battery mean every part of the device disappears: the stimulation system described by MIT retained a circuit board that would pass through the digestive tract.

Yet the broader design principle is already worth exploring.

We often judge technology by what it adds: more capability, more information, more control. In healthcare, we should also ask how much effort, uncertainty or intervention it leaves for the person receiving care.

Designing an ending requires that question to be asked early. It brings responsibility for a technology’s entire useful life into the first decisions about its materials and purpose.

This battery offers a small, tangible expression of that thinking. Its ultimate impact will depend on the evidence still to come. Its invitation is immediate: imagine medical technology whose departure is planned as carefully as its arrival.

For the patient, the most meaningful legacy could be the benefit it leaves behind.